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The present study aimed to determine the effect of thyroid hormone dysfunction on brown adipose 
tissue activity and white adipose tissue browning in mice. Twenty randomized female C57BL/6NTac 
mice per treatment group housed at room temperature were rendered hypothyroid or hyperthyroid. 
In-vivo small animal 18F-FDG PET/MRI was performed to determine the effects of hypo- and 
hyperthyroidism on BAT mass and BAT activity. Ex-vivo 14C-acetate loading assay and assessment of 
thermogenic gene and protein expression permitted analysis of oxidative and thermogenic capacities 
of WAT and BAT of eu-, hyper and hypothyroid mice. 18F-FDG PET/MRI revealed a lack of brown adipose 
tissue activity in hypothyroid mice, whereas hyperthyroid mice displayed increased BAT mass alongside 
enhanced 18F-FDG uptake. In white adipose tissue of both, hyper- and hypothyroid mice, we found a 
significant induction of thermogenic genes together with multilocular adipocytes expressing UCP1. 
Taken together, these results suggest that both the hyperthyroid and hypothyroid state stimulate WAT 
thermogenesis most likely as a consequence of enhanced adrenergic signaling or compensation for 
impaired BAT function, respectively.
Thyroid hormones (TH) are intimately involved in the regulation of energy metabolism. Administration of TH 
to mammals leads to an increase in basal metabolic rate and thermogenesis1. The important role of TH in the 
regulation of body temperature homeostasis is perhaps best reflected by the cold or heat intolerance of animals 
and humans with hypothyroidism or hyperthyroidism, respectively2. Under conditions of thermoneutrality, core 
body temperature can be maintained in the absence of any thermoregulatory process (e.g. shivering). However, 
under conditions of cold exposure adaptive thermogenesis occurs through a compensatory increase in sympa-
thetic nervous system tone (SNS) which, in concert with TH, accelerates energy expenditure (EE) and increases 
body temperature3.
Numerous studies primarily performed on animal models have investigated the mechanism of TH for activat-
ing brown adipose tissue (BAT). Findings from different TR knockout mice (e.g. TRα , TRβ , TRα 1+ m) and the 
use of isoform-selective agonists indicate specific roles for TH-adrenergic interactions in BAT and white adipose 
tissue(WAT)4–10. Early studies in thyroidectomized and hypothyroid rats demonstrated the relevance of BAT spe-
cific type II iodothyronine deiodinase Dio2 as a local and systemic source of 3,3′ ,5-triiodothyronine (T3) under 
cold exposure and for the first time provided evidence for T3 in the enhancement of the thermogenic response 
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to sympathetic stimulation11,12. This suggests that the subsequent heat liberation is actually a result of synergism 
between norepinephrine (NE) and T3 signaling13. The significance of the central nervous system in TH activa-
tion of BAT was demonstrated in rats in which central administration of T3, via the inhibition of hypothalamic 
AMP-activated protein kinase (AMPK), induces thermogenic gene expression in BAT through stimulation of 
sympathetic nervous system (SNS) activity14. Additionally, SNS stimulation results in activation of β -adrenergic 
receptors (β -AR) by NE which induces both the enhanced thermogenic activity of existing brown adipocytes 
and the recruitment of new cells to BAT depots1. Energy release is accomplished by the activity of UCP1, a 
BAT-specific mitochondrial uncoupling protein1. With regards to WAT, a distinct population of UCP1-positive 
adipocytes arises within subcutaneous and visceral depots of mice in response to cold exposure15,16 and β 3 adren-
ergic receptor agonist treatment15,17,18. To date it remains a matter of controversy as to whether these cells, entitled 
“brite” or “beige” adipocytes, are produced from the conversion of existing white adipocytes and/or the differen-
tiation of WAT resident progenitor cells, leading to a process called “browning”19–21.
There is preliminary evidence that suggests a role for TH in the induction of beige adipocytes in WAT. In 
human multipotent adipose-derived stem cells, 3–10 day treatment with T3 induced UCP1 expression which 
was most pronounced during the differentiation phase and was dependent on the presence of thyroid hormone 
receptor β (TRβ )22. Similarly, treatment of mice with the TRβ specific agonist GC-1 leads to induction of adap-
tive thermogenesis in subcutaneous WAT, increased energy expenditure, and restoration of cold tolerance in 
cold-intolerant mice independent from BAT activity23,24. Furthermore, in mice centrally administered T3 leads 
to the recruitment of BAT in inguinal WAT which is accompanied by increased energy expenditure and body 
temperature. Since the effect was abolished in UCP1 KO mice, the findings highlight the significance of UCP1 as 
a central relais modulating the central effects of TH25. Furthermore, a novel circuit for the control of TH feedback 
in the brain via the Liver X receptor α and β has recently been published26. LXRα β −/− mice display increased TH 
serum level combined with changes in expression of genes associated with TH synthesis and TH transport as 
well as prominent UCP1 staining in the subcutaneous adipose depot26. In a positron emission tomography (PET) 
study of a patient with a history of thyroid cancer, systemic administration of TH led to BAT activation in perium-
bilical WAT indicating that browning had occurred as a result of T4 supplementation for 14 days27.
Despite the significance of TH for adaptive thermogenesis, there is currently limited understanding of whether 
and how different thyroid states, i.e. hypo- and hyperthyroidism, regulate BAT thermogenesis as well as the ther-
mogenic activity of WAT. Therefore, the present study aimed to determine TH induced effects on (I) BAT activity 
Figure 1. Thyroid state and phenotypic characterization of hyper- hypo- and euthyroid mice. (A) Total T4 
and free T3 serum concentrations, (B) Hepatic expression of TH-responsive genes, (C) Final body weight and 
(D) Lean and fat mass and (E) Body temperature and (F) food intake of eu-, hyper-, and hypothyroid mice. 
n = 10 mice per group; data are presented as mean and SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
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and (II) WAT browning in a mouse model of thyroidal dysfunction with a view to incorporate the results into the 
context of TH-regulated effects on whole-body energy homeostasis.
Results
Both hypo- and hyperthyroidism induce brown fat biogenesis. Comparison of total T4 and free T3 
serum concentrations between eu-, hyper- and hypothyroid mice confirmed the hyperthyroid and hypothyroid 
state of the animals (Fig. 1A). This finding is further substantiated by the differential hepatic expression of the 
TH-responsive genes deiodinase 1 (Dio1), thyroxine-binding globulin (Tbg) and pyruvate dehydrogenase kinase 
4 (Pdk4) (Fig. 1B). The mRNA level of Dio1 and Pdk4 in liver increased significantly upon T4-treatment and 
decreased significantly in hypothyroid animals. In addition, induction of Tbg, negatively regulated by TH, con-
firmed the hypothyroid state (Fig. 1B).
Hyperthyroid mice showed slightly enhanced weight gain at the end of treatment while hypothyroid ani-
mals displayed significantly decreased body weights (Fig. 1C). While there was no change in body composition 
between hyperthyroid and euthyroid animals, hypothyroid mice had significantly reduced lean mass and concur-
rently increased body fat (8.9 ± 0.9%) compared with euthyroid (6.8 ± 0.3%) and hyperthyroid mice (5.7 ± 0.3%; 
Fig. 1D). Core body temperature was significantly decreased in hypothyroid mice (34.9 ± 0.2 °C) compared with 
hyperthyroid (36.2 ± 0.2 °C) and euthyroid mice (35.7 ± 0.3 °C); Fig. 1E). Furthermore, food intake decreased in 
hypothyroid animals (Fig. 1F).
In view of the striking differences in core body temperature and body fat distribution between hyper- and 
hypothyroid mice, we next asked to which extent WAT depot contributes to TH induced thermogenesis. 
Consistent with the finding of increased fat mass, adipocytes from hypothyroid mice were larger in size with 
increased lipid accumulation in iWAT and gWAT when compared with hyper- and euthyroid mice (Fig. 2A). In 
addition we observed moderate increases in thermogenic gene program in the white fat depots of both hypo- and 
hyperthyroid mice as compared to euthyroid littermates. Strikingly, Ucp1 gene expression was upregulated by 
about 40-fold in iWAT of hypo- and hyperthyroid mice compared to euthyroid controls. Moreover, we observed 
a significant increase in Ucp1 mRNA in gWAT, which is considered to have a much lower capacity to induce ther-
mogenic gene programs (Fig. 2B). Of interest, the zinc finger protein Zfp423, which is an essential determinant of 
preadipocyte commitment28,29, was predominantly upregulated in WAT of hypothyroid mice (Fig. 2B).
Histological examination of the white fat depots revealed the presence of abundant islets with a distinctive 
multilocular appearance of adipocytes which were positively stained for UCP1 in both, hyper- and hypothyroid 
states (Fig. 3A).
Figure 2. Histology and gene thermogenic expression in WAT. (A) Cell size distribution of adipocytes from 
gWAT and iWAT (n = 10/group); (B) Expression of genes associated with thermogenesis, recruitment, beiging 
and β -adrenergic signaling (n = 7–10/group). Data are presented as mean and SEM (*p < 0.05, **p < 0.01, 
***p < 0.001).
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We then investigated whether the presence of brown fat-like cells has consequences for fatty acid oxidation. 
As demonstrated in Fig. 3B, the highest uptake of 14C-acetate was found in both iWAT and gWAT of hyperthy-
roid mice in comparison with hypo- and euthyroid mice. This was accompanied by a significantly higher level of 
Ardb1 expression in iWAT of hyperthyroid mice, whereas the expression Ardb1 and Ardb3 in gWAT of hypo- and 
euthyroid mice did not change (Fig. 3C).
Hypothyroidism is associated with enhanced β3-adrenergic tone in BAT. Given the differences 
in core body temperature despite the activation of the thermogenic program in WAT at room temperature, 
we next asked whether this is due to changes in the thyroid-adrenergic axis induced by thyroidal dysfunction. 
Immunohistochemical staining of tyrosine hydroxylase, which is the rate-limiting enzyme for catecholamine 
synthesis30, revealed no differences in abundance in the BAT of hyperthyroid and hypothyroid mice (data not 
shown). Furthermore, while we did not observe changes in gene expression of the β -adrenergic receptor 1 
(Ardb1) in BAT, there was a significant increase in gene expression of Ardb3 in BAT of hypo- vs hyperthyroid 
mice (Fig. 4A).
BAT is profusely innervated by sympathetic nerve terminals with norepinephrine (NE) acting via β -ARs31. 
Therefore, we next determined the concentrations of circulating NE and epinephrine in the experimental groups. 
Intriguingly, we found that concentrations of NE only increased in hypothyroid mice whereas epinephrine 
increased in both hyperthyroid and hypothyroid mice compared to euthyroid mice (Fig. 4B). The activity of the 
Figure 3. UCP-1 expression and fatty acid oxidation in WAT. (A) Representative Ucp1 immunohistochemical 
stainings in gWAT and iWAT in eu-, hyper- and hypothyroid mice; (B) ex-vivo 14C-palmitate uptake in 
n = 10 mice/group. (C) Ardb1 and Ardb3 mRNA expression in gWAT and iWAT (n = 5 mice/group). Data are 
presented as mean and SEM (*p < 0.05; **p < 0.01).
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Figure 4. Characterization of the thyroid-adrenergic axis. (A) Expression of Ardb1 and Ardb3 in BAT 
(n = 7–10/group). (B) Circulating levels of epinephrine and norepinephrine (n = 10/group); (C) BAT DIO2 
activity (n = 4–5/group). Data are presented as mean and SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
Figure 5. Characterization of BAT. (A) Representative hematoxylin and eosin sections; (B) Lipid droplet size 
and number (n = 10/group); (C) Expression of genes associated with thermogenesis, lipolysis, recruitment and 
β -adrenergic signaling (n = 7–10/group); (D) Quantification of BAT UCP1, pHSL and HSL protein by Western 
Blot analysis and normalization against β -actin as loading control (n = 4 mice/group). Data are presented as 
mean and SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
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Dio2 in hypothyroid BAT was 20-fold increased compared to hyperthyroid mice (p < 0.05). In hyperthyroid BAT 
Dio2 activity was significantly lower than in euthyroid controls (p < 0.01; Fig. 4C).
Different morphology and gene expression in BAT of hypo- and hyperthyroid mice. In order to 
further unravel the discrepancies between hypothermia despite increased adrenergic signalling and WAT brown-
ing in hypothyroid mice we next investigated BAT metabolism.
Histological examination of interscapular BAT revealed gross differences in cell morphology. Whereas BAT 
of euthyroid mice contained mixed regions of white and brown adipocytes, the BAT of hypothyroid mice con-
tained predominantly adipocytes with unilocular lipid droplets of intermediate size between WAT and BAT. 
Hyperthyroid BAT displayed a distinct morphology with a decreased cell size of the mainly multilocular adipo-
cytes (Fig. 5A+B).
Gene expression analysis of thermogenic markers, including Ucp1, Fgf21, Cidea, Dio2 and Elovl3, revealed 
a remarkable collective overexpression in the hypothyroid BAT compared with hyperthyroid mice (Fig. 5C). 
However, the high induction of Ucp1 mRNA in hypothyroid mice was not reflected on the level of UCP1 protein 
expression. Furthermore, there was no difference in UCP1 protein expression between hyperthyroid and euthy-
roid mice (Fig. 5D). In contrast, in hyperthyroid BAT we found an increased activation of β -adrenergic signaling 
as demonstrated by higher gene expression of the hormone-sensitive lipase (Hsl) and adipose triglyceride lipase 
(Atgl; Fig. 5C) together with an increased Ser660-phosphorylation of HSL (Fig. 5D).
Volume and activity of BAT is distinctively regulated in hypo- and hyperthyroid mice. Given 
the magnitude of thermogenic gene expression in BAT of hypothyroid mice together with the increased stim-
ulation of the TH-adrenergic axis, hypothyroid mice cannot compensate for hypothermia. Therefore we next 
addressed whether this is due to defects in BAT activity. First, to determine the oxidative capacity in BAT, we 
performed ex-vivo 14C-acetate uptake assay and observed a significant increase in fatty acid oxidation in BAT of 
hyperthyroid mice (74.0 ± 14.0 dpm/count) as compared to hypothyroid mice (18.9 ± 1.95 dpm/count; p < 0.01). 
There was no significant difference between hypo- and euthyroid mice (47.2 ± 14.5 dpm/count; Fig. 6A). Second, 
we used a combined PET- and MR-based delineation of active BAT to investigate whether there are differences 
in BAT formation between the experimental mouse groups. Hyperthyroid mice contained a higher volume of 
active iBAT (0.06 ccm ± 0.01 ccm) when compared to euthyroid (0.04 ccm ± 0.01 ccm; p < 0.05) and hypothyroid 
mice (0.03 ccm ± 0.01 ccm; Fig. 6B). We then asked whether the increase in amount of BAT also correlates with 
increased BAT activity. Metabolically active BAT depots with symmetrical uptake of 18F-FDG were observed in 
all three groups being most marked in the hyperthyroid group (Fig. 6C). The SUVR of 18F-FDG accumulation 
Figure 6. In-vivo 18F-FDG PET/MRI and ex-vivo 14C-acetate uptake assay study for BAT amount and 
activity. (A) Ex vivo 14C-acetate uptake in BAT (n = 10/group). (B) Active iBAT volume evaluated by PET/MR 
imaging. (C) Longitudinal (left) and transversal (right) 18F-FDG PET/MR fused images and (D) SUVR of iBAT 
in euthyroid, hyperthyroid and hypothyroid mice. (D) Proportion of activated BAT (% of total BAT). Data are 
presented as mean and SEM (*p < 0.05, **p < 0.01, ***p < 0.001).
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in iBAT was significantly decreased in hypothyroid mice vs. euthyroid mice (8.9 ± 1.3 vs. 18.9 ± 3.8; p < 0.05; 
Fig. 6D). Furthermore, there was a trend towards an increased 18F-FDG accumulation in hyperthyroid compared 
to euthyroid and hypothyroid mice mice (21.99 ± 5.0 vs. 18.9 ± 3.8 and 8.9 ± 1.3, p = 0.06, respectively).
Finally, to determine to which extent the MR based iBAT volume is metabolically activated, the respective 
18F-FDG avid iBAT with a SUV threshold of > 2 was adjusted to the MR based iBAT volume. Hyperthyroid mice 
presented with an active iBAT fraction of 94% the highest BAT activity. In contrast, hypothyroid mice showed 
only in 81% of the interscapular adipose tissue relevant metabolic activity. In iBAT of euthyroid mice we found 
that 92% is activated (Fig. 6E).
Discussion
The present study provides new evidence of how TH affects thermogenesis in both brown and white adipose 
depots. For the first time with regard to metabolic activity of BAT, we were able to identify a distinct profile in 
hyper- and hypothyroid mice at room temperature. First, regarding the amount of BAT, the in vivo 18F-FDG PET/
MRI-estimated BAT volumes gave first evidence for an increased total amount of BAT in hyperthyroid mice 
compared to hypo- and euthyroid animals (Fig. 6B). Second, although hypo- and euthyroid animals contained 
detectable BAT, hyperthyroid mice displayed an increased metabolic activity as determined by 18F-FDG uptake 
(Fig. 6C+D). In line with this observation, fatty acid oxidation activity in BAT was increased in hyperthyroid 
mice as determined by the uptake of 14C-acetate (Fig. 6A). The opposite metabolic profile was found in hypothy-
roid animals, which display significantly lower uptake of 18F-FDG and of 14C-acetate in BAT when compared to 
hyperthyroid mice (Fig. 6A–D).
The observation of active BAT in all three experimental groups emphasizes the significance of thermal con-
ditions for metabolic control irrespective of thyroidal state. As discussed by Nedergaard et al. under sub-thermal 
conditions (for mice 18–22 °C) BAT derived heat will be used to maintain body temperature32. Paradoxically, 
the low BAT activity in hypothyroid animals was associated with a strong increase of thermogenic genes (Ucp1, 
Dio2, Fgf21, Cidea, and Elovl3; Fig. 5) and with a significant upregulation of the adrenergic system, as evidenced 
by significant increases of Ardb3 and NE concentrations in hypothyroid animals (Fig. 4). Although NE per se is 
not an index of NE release or sympathetic tone, these data suggest an increase in norepinephrine outflow to the 
periphery as a compensatory response to maintain body temperature. This finding is principally in agreement 
with observations in cold exposed hypothyroid rodents6,33.
Interestingly, in iWAT and gWAT of hypothyroid mice we detected features of adipose tissue browning, evi-
denced by an increased expression of brown specific genes (Ucp1, Cidea, and Elovl3; Fig. 2) and a multilocular 
UCP1-positive phenotype (Fig. 3). Collectively, these data suggest a compensatory WAT browning as a response 
of decreased heat production due to BAT inactivity in hypothyroid mice. Indeed, decreased BAT thermogenesis 
in mice lacking bone morphogenetic protein (BMPR1A) is associated with increased circulating NE and a com-
pensatory browning of iWAT and eWAT in a very similar fashion to the hypothyroid mice in the present study34. 
The idea of heat compensation is further substantiated by the observation of enriched expression of the zinc finger 
protein 423 (Zfp423) in WAT and BAT selectively in hypothyroid mice (Figs 2+ 5). Gupta et al. demonstrated that 
Zfp423+ endothelial cells undergo an endothelial-mesenchymal transition into Zfp423+ Pparg+ pericytes that 
serve as a pool of committed pre-adipocytes29. Thus, the increased Zfp423 expression in the adipose tissues of 
hypothyroid mice likely suggests the formation of beige adipocytes by recruitment and de-novo differentiation of 
progenitor cells as has been demonstrated by cold exposure or adrenergic β3-AR agonist treatment28.
The observation of browning of white adipose tissue was also made in white adipose tissues of hyperthy-
roid mice, where in particular, established markers for adipose tissue browning such as Ucp1, Fgf21, Cidea, and 
Elovl3 were upregulated (Fig. 2). In addition, hyperthyroid mice were characterized by a significant increase 
in Ardb1 expression in iWAT (Fig. 3C). Recent studies demonstrated that the absence of the β1-AR receptor 
impairs NE-induced de-novo brown adipogenesis in BAT35. Conversely, β1-AR transgenic mice are resistant to 
diet-induced obesity and display a high abundance of adipocytes expressing Ucp1 in WAT36. With the results 
gained in the present study we cannot conclude whether or not central effects of T3 contribute to the observed 
WAT browning. However, evidences from a recent study by Alvarez-Crespo et al. suggest a coordinated action 
of central hyperthyroidism on WAT browning. Thus, the authors for the first time demonstrated that central T3 
administration in mice induces UCP1 dependent thermogenesis in BAT and browning of WAT25. Also, similar to 
the observed increased BAT amount in our cohort of hyperthyroid mice, Alvarez-Crespo reported BAT recruit-
ment upon central T3 infusion even at thermoneutrality25. Notably, keeping in mind that the hyperthyroid state of 
our mouse cohort is rather mild it is even more interesting to observe the significant effects on BAT recruitment 
and WAT browning. Further work will be necessary to address the extent of centrally induced T3 effects, i.e. by 
the determination of hypothalamic AMPK and ACC in our model of hyperthyroidism37.
Collectively, our data provide first evidence for differential mechanisms contributing to WAT browning 
dependent upon altered thyroidal state. This is most apparent in hypothyroid mice that exhibit increased adi-
pogenesis and de-novo differentiation of brown adipocytes potentially as a compensatory mechanism to hypo-
thermia resulting from BAT inactivity. In hyperthyroid mice, it can be hypothesized that increased β -adrenergic 
activation contributes to WAT browning most likely by central effects of TH. However, it has to be emphasized 
that with the current data we cannot exclude potential non cell-autonomous contributions from the SNS to adi-
pose tissue browning irrespective of thyroidal state. Thus, in order to rule out that temperature as opposed to thy-
roidal state is the underlying reason for WAT browning, further studies should be performed under temperatures 
where sympathetic stimulation of facultative thermogenesis is depressed i.e. thermoneutrality (30 °C)32.
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Methods
Mice. Nine week-old female C57BL/6NTac mice were purchased from Taconic Europe (Lille Skensved, 
Denmark). The mice were housed in pathogen-free facilities in groups of three at 22 °C with a 12:12-h dark-light 
cycle (lights on at 06:00 h). Guidelines were approved by the local authorities of the State of Saxony, Germany as 
recommended by the responsible local animal ethics review board (Regierungspräsidium Leipzig, TVV04/12, 
Germany). All experiments with mice were carried out according to the approved guidelines.
After one week of adaptation, induction of hyper- or hypothyroidism started at the age of ten weeks with 
n = 20 mice per experimental group. Mice were rendered hyperthyroid by application of L-thyroxine at a dose 
of 2 μ g/ml diluted in drinking water for 4 weeks38. Hypothyroidism was induced by feeding an iodine-free chow 
diet supplemented with 0.15% propylthiouracil (PTU, catalog TD 97061; Harlan Teklan, Madison, WI, USA) for 
4 weeks. Euthyroid mice fed standard chow diet (Altromin GmbH, Lage, Germany) served as controls.
Body composition. Body weight was recorded once a week and after 4 weeks of treatment. Whole body 
composition (fat mass, lean mass and total body water) was determined in conscious mice by using nuclear 
magnetic resonance technology with an EchoMRI700™ instrument (Echo Medical Systems, Houston, TX, USA). 
Ten animals per experimental group were measured. Rectal body temperature was measured in fed mice between 
8:00–9:00 am. Mice were sacrificed by CO2 inhalation at the age of 14 weeks.
18F-FDG PET/MRI of BAT activation. In order to investigate the influence of thyroidal status on BAT 
activity, small animal PET/magnetic resonance (MR) imaging studies were performed using a dedicated 
high-resolution scanner (nanoScan, Mediso Medical Imaging Systems, Hungary). Anaesthetized (induction at 
4%, maintenance at 1.8% isoflurane in 60%/40% oxygen/air) mice were injected intraperitoneally with 14.5 ± 1.3 
MBq 18F-FDG followed by a PET/MR scan from 30-60 minute post-injection in list mode. The data were recon-
structed dynamically into 5-min time frames (OSEM, 4 iterations, 6 subsets, MR-based attenuation and scatter 
correction).
A T1-weighted MR image (Gradient Echo sequence (GRE), TE = 3.2 ms (out phase), TE = 6.4 ms (in phase), 
TR = 15.0 ms, Flip Angle = 25°; NEX = 2) served for anatomical orientation with individual PET datasets as well 
as for threshold based delineation of BAT in the intrascapular region. The 18F-FDG uptake was determined using 
mean standardized uptake values (SUV) in PET/MR based volumes of interest (VOIs) in the intrascapular BAT 
(iBAT) and liver. To rule out an impact of alterations in the physiological 18F-FDG distribution associated with 
a hyperthyroid or hypothyroid state, 18F-FDG uptake was accessed semi-quantitatively. Therefore, SUV ratios 
(SUVR) were calculated to normalize iBAT uptake to unspecific liver uptake39,40. Furthermore, iBAT volume was 
retrieved by a MR-based delineation of fatty tissue in the intrascapular region. Active iBAT volume was defined 
as iBAT with an increased 18F-FDG uptake of SUV > 2. Subsequently, the fraction of active iBAT was calculated 
as percentage of active iBAT volume out of total adipose tissue volume delineated by MR in the interscapular 
region. The SUVR and active iBAT volume between the groups were compared using 1-way ANOVA, followed by 
Bonferroni’s multiple comparison test, using Prism 6.0 (GraphPad, San Diego, Ca, USA). Values of p < 0.05 were 
considered significant.
Ex-vivo 14C-acetate loading assay. To quantify the oxidative capacity of WAT and BAT in hyper-, hypo-, 
and euthyroid mice, we performed an ex-vivo 14C-acetate loading assay that measures the incorporation of radi-
oactively labeled acetate into triacyl glycerides (TAG) as described elsewhere41.
Adipocyte cell size and number. To determine cell size distribution and adipocyte number, 200 μ l aliquots 
of adipocyte suspension were fixed with osmic acid, incubated for 48 h at 37 °C, and counted in a Coulter counter 
(Multisizer III; Beckman Coulter, Krefeld, Germany)42.
Serum concentrations of thyroxine and serum metabolites. Serum TT4 and fT3 concentrations were 
measured using commercial ELISA kits according to the manufacturer’s instructions (DRG Instruments GmbH, 
Germany). Serum concentrations of epinephrine and norepinephrine were determined using a commercially 
available ELISA kit (2-CAT (A-N) Research ELISA; Rocky Mountain Diagnostics, Inc., Colorado Springs, USA). 
The immunoassays were performed according to the manufacturer’s instructions.
Deiodinase type 2 activity. Activity of type 2 deiodinase were determined in duplicates in BAT homogen-
ates (100 μ g protein per 100 μ l reaction) as described43,44.
Western Blot analysis. Western Blot analysis was performed on samples of inguinal WAT (iWAT), gonadal 
WAT (gWAT) and BAT as described previously45. The following antibodies and dilutions were used: mouse poly-
clonal anti-Ucp1 antibody (1:500; Merck Millipore; Darmstadt, Germany), pHSL and HSL(1:1000; Cell Signaling 
Technology, Danvers, USA). Blots were visualized by enhanced chemiluminescence (Pierce, Milwaukee, USA).
Quantitative real-time-PCR (qPCR). For quantification of gene expression qPCR was performed using 
the LightCycler System LC480 and LightCycler-DNA Master SYBR Green I Kit (Roche, Mannheim, Germany) 
as described previously46. Primer sequences are available on request. Gene expression was calculated by the 
delta-delta CT method using 36B4 as a reference gene47. Relative gene expression was calculated by setting the 
mean of the euthyroid control group to 1 and then calculating each individual value of the three groups of mice 
studied.
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Immunohistochemistry. Tissues were harvested, fixed in 4% paraformaldehyde (pH 7.4) for 24 h at 4 °C 
and subsequently embedded in paraffin. Immunohistochemical analysis was performed on BAT and WAT sec-
tions rabbit anti-UCP1 polyclonal antibody (ab23841; Abcam, Cambridge, UK). Sections were rinsed thoroughly 
and incubated with labelled polymer HRP anti-rabbit (Dako Envision™ + ; Dako, Hamburg, Germany) for 1 h. 
Visualization was performed with 3,3′ -diaminobenzidine. Microscopic examination was performed using an 
Axio Observer Microscop (Carl Zeiss, Jena, Germany). Images were obtained using ZEN2012 software (Carl 
Zeiss, Germany).
Statistical Analyses. Data are shown as mean ± SEM. Statistical significance was determined by Student´s 
t-test for comparison of two experimental groups or by ANOVA for comparison of multiple conditions followed 
by Bonferroni’s multiple comparison test, using Prism 6.0 (GraphPad, San Diego, Ca, USA). P values less or equal 
to 0.05 were considered to be significant.
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